✦ LIBER ✦

HPV-16 Vaccine Effective in Preventing Persistent Infection and Cin

Book ID: 115069922
Publisher: American Cancer Society
Year: 2003
Tongue: English
Weight: 33 KB
Volume: 53
Category: Article
ISSN: 0007-9235
DOI: 10.3322/canjclin.53.1.3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HPV-16 vaccine prevented persistent HPV-

HPV-16 vaccine prevented persistent HPV-16 infection and the development of HPV-16 related cervical neoplasia

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB

HPV vaccine efficacy in preventing persi

HPV vaccine efficacy in preventing persistent cervical HPV infection: A systematic review and meta-analysis

✍ G. La Torre; C. de Waure; G. Chiaradia; A. Mannocci; W. Ricciardi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 485 KB

A bivalent vaccine prevented incident an

A bivalent vaccine prevented incident and persistent infection with HPV types 16 and 18 in young women

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 82 KB

A quadrivalent vaccine prevented persist

A quadrivalent vaccine prevented persistent infection and disease associated with HPV types 6, 11, 16, and 18

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Human papillomavirus type 16 (HPV-16) vi

Human papillomavirus type 16 (HPV-16) viral load and persistence of HPV-16 infection in women infected or at risk for HIV

✍ Julie Fontaine; Catherine Hankins; Deborah Money; Anita Rachlis; Karina Pourreau 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 298 KB

HPV16/18 vaccination to prevent cervical

HPV16/18 vaccination to prevent cervical cancer in The Netherlands: Model-based cost-effectiveness

✍ Veerle M.H. Coupé; Joost van Ginkel; Hester E. de Melker; Peter J.F. Snijders; C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 259 KB

## Abstract We evaluated the cost‐effectiveness of HPV16/18 vaccination for girls aged 12 years in The Netherlands in addition to cervical cancer screening. For this purpose, we developed a simulation model that describes the relation between each of the high‐risk human papillomavirus (hrHPV) types